|
| 37246824 | International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance. | Am J Surg Pathol | 2024 |
| 37919231 | Engineering the future of 3D pathology. | J Pathol Clin Res | 2024 |
| 37558528 | Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools. | Clin Genitourin Cancer | 2024 |
| 37548751 | Redefining and capturing pre-analytic deficiencies in an anatomical pathology laboratory: a quality improvement initiative. | Virchows Arch | 2024 |
| 37284047 | International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members. | Eur Urol Open Sci | 2023 |
| 37546794 | Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes. | bioRxiv | 2023 |
| 37680023 | ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases. | Histopathology | 2023 |
| 35466737 | The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis. | Int J Surg Pathol | 2023 |
| 35816346 | Morphologic Pattern, Frequency, and Spatial Distribution of Lymphovascular Invasion Foci in Radical Prostatectomy Specimens. | Int J Surg Pathol | 2023 |
| 34103388 | Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression. | J Clin Pathol | 2022 |
| 35676330 | Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification. | Mod Pathol | 2022 |
| 36230835 | Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification. | Cancers (Basel) | 2022 |
| 35074179 | The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes. | Pathology | 2022 |
| 34878188 | Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease. | Prostate | 2022 |
| 35027623 | Upregulation of IFNÉ£-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma. | Sci Rep | 2022 |
| 34812724 | Target prostate biopsies: How best to report in synoptic format? | Can Urol Assoc J | 2022 |
| 32471889 | Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study. | J Clin Pathol | 2021 |
| 34509050 | Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma. | Pathol Res Pract | 2021 |
| 34453155 | Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry. | Nat Rev Urol | 2021 |
| 34152685 | A proteomic investigation of isogenic radiation resistant prostate cancer cell lines. | Proteomics Clin Appl | 2021 |
| 33172830 | Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study. | Radiother Oncol | 2021 |
| 33077335 | Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy. | Eur J Cancer | 2021 |
| 33175216 | The impact of pre-analytical parameters on class II biomarkers by immunohistochemistry: concordance across four tissue processing protocols. | Virchows Arch | 2021 |
| 31161221 | Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome. | J Natl Cancer Inst | 2020 |
| 31874245 | miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA. | Cancer Lett | 2020 |
| 31919144 | Correlation of mismatch repair protein deficiency, PD-L1 and CD8 expression in high-grade urothelial carcinoma of the bladder. | J Clin Pathol | 2020 |
| 32861170 | Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations. | Pathol Res Pract | 2020 |
| 33022560 | Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer? | Pathol Res Pract | 2020 |
| 32188330 | A Practical Approach to Investigating Cross-Contaminants in the Anatomical Pathology Laboratory. | Int J Surg Pathol | 2020 |
| 31243779 | Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma. | Histopathology | 2020 |
| 31485721 | Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder. | Virchows Arch | 2020 |
| 30694165 | Value of Increasing Biopsy Cores per Target with Cognitive MRI-targeted Transrectal US Prostate Biopsy. | Radiology | 2019 |
| 30160779 | Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set. | Histopathology | 2019 |
| 31381885 | Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells. | Am J Pathol | 2019 |
| 31177561 | Gleason grade patterns in nodal metastasis and corresponding prostatectomy specimens: impact on patient outcome. | Histopathology | 2019 |
| 31322262 | MicroRNAâ¿¿198 suppresses prostate tumorigenesis by targeting MIB1. | Oncol Rep | 2019 |
| 31043833 | A Canadian guideline on the use of next-generation sequencing in oncology. | Curr Oncol | 2019 |
| 28768702 | Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder. | J Clin Pathol | 2018 |
| 30075156 | Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue types. | Hum Pathol | 2018 |
| 29962847 | Harmonization of PD-L1 testing in oncology: a Canadian pathology perspective. | Curr Oncol | 2018 |
| 29896907 | Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy. | Mol Oncol | 2018 |
| 30257853 | Immune infiltrates and PD-L1 expression in treatment-naïve acinar prostatic adenocarcinoma: an exploratory analysis. | J Clin Pathol | 2018 |
| 29947424 | Basal-subtype bladder tumours show a 'hot' immunophenotype. | Histopathology | 2018 |
| 29776013 | Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy. | Histopathology | 2018 |
| 29750666 | PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell Carcinoma. | Am J Surg Pathol | 2018 |
| 27530957 | Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway. | Histopathology | 2017 |
| 28342221 | p53 immunohistochemistry in high-grade urothelial carcinoma of the bladder is prognostically significant. | Histopathology | 2017 |
| 28984673 | Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis. | Am J Surg Pathol | 2017 |
| 28756619 | Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin? | Histopathology | 2017 |
| 27993699 | Gastroesophageal Mucosal Injury after Cholecystectomy: An Indication for Surveillance? | J Am Coll Surg | 2017 |